M. F. Morelli

Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study.

S. Iacobelli, E. Ricevuto, P. Marchetti, 2010, Oncology reports.

Docetaxel in Patients with Anthracycline-Resistant Advanced Breast Cancer

A. Amodio, P. Foggi, P. Vici, 2000, Oncology.

The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study

P. Queirolo, M. Del Vecchio, V. Chiarion Sileni, 2023, Cancers.

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study

O. Nanni, R. Labianca, P. Tagliaferri, 2023, EClinicalMedicine.

Knowledge and attitudes of Italian medical oncology residents toward the approach and treatment of pain.

M. Valenti, P. Marchetti, G. Varrassi, 2003, Journal of pain and symptom management.